Clinical Trials Directory

Trials / Completed

CompletedNCT06290674

Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile

Effect of Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile in Obese Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
45 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.

Detailed description

Postmenopausal women are usually troubled by increasing weight and waist circumference caused by obesity and androcidal fat redistribution. Abdominal adiposity, defined as a waist circumference ≥88cm in women, measured in the upright position, plus significant elevated lipid profile values. In postmenopausal women, a higher level of physical activity was associated with a more optimal body composition, including lower adiposity and higher lean mass. Management of abdominal obesity involves different techniques i.e., dietary management, exercise therapy, even lifestyle management, and pharmacological management, and surgical interventions. Extracorporeal shockwave provides cavitation phenomena that may facilitate better management of abdominal obesity. Thus, current study will be conducted to investigate effect of extracorporeal shockwave on abdominal adiposity and lipid profile in obese post-menopausal women.

Conditions

Interventions

TypeNameDescription
OTHERExtracorporeal Shockwave therapy2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.
OTHERBalanced low-calorie diet1500 k/cal for 6 weeks

Timeline

Start date
2022-09-11
Primary completion
2024-01-01
Completion
2024-02-01
First posted
2024-03-04
Last updated
2024-07-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06290674. Inclusion in this directory is not an endorsement.